M. TEK Et Al. , "Levosimendan and dobutamine have a similar profile for potential risk for cardiac arrhythmias during 24-hour infusion in patients with acute decompensated heart failure," Türk Kardiyoloji Derneği Arşivi , vol.38, no.5, pp.334-340, 2010
TEK, M. Et Al. 2010. Levosimendan and dobutamine have a similar profile for potential risk for cardiac arrhythmias during 24-hour infusion in patients with acute decompensated heart failure. Türk Kardiyoloji Derneği Arşivi , vol.38, no.5 , 334-340.
TEK, M., ÇAVUŞOĞLU, Y., DEMİRÜSTÜ, C., BİRDANE, A., ÜNALIR, A., GÖRENEK, B., ... GÖKTEKİN, Ö.(2010). Levosimendan and dobutamine have a similar profile for potential risk for cardiac arrhythmias during 24-hour infusion in patients with acute decompensated heart failure. Türk Kardiyoloji Derneği Arşivi , vol.38, no.5, 334-340.
TEK, MÜJGAN Et Al. "Levosimendan and dobutamine have a similar profile for potential risk for cardiac arrhythmias during 24-hour infusion in patients with acute decompensated heart failure," Türk Kardiyoloji Derneği Arşivi , vol.38, no.5, 334-340, 2010
TEK, MÜJGAN Et Al. "Levosimendan and dobutamine have a similar profile for potential risk for cardiac arrhythmias during 24-hour infusion in patients with acute decompensated heart failure." Türk Kardiyoloji Derneği Arşivi , vol.38, no.5, pp.334-340, 2010
TEK, M. Et Al. (2010) . "Levosimendan and dobutamine have a similar profile for potential risk for cardiac arrhythmias during 24-hour infusion in patients with acute decompensated heart failure." Türk Kardiyoloji Derneği Arşivi , vol.38, no.5, pp.334-340.
@article{article, author={MÜJGAN TEK Et Al. }, title={Levosimendan and dobutamine have a similar profile for potential risk for cardiac arrhythmias during 24-hour infusion in patients with acute decompensated heart failure}, journal={Türk Kardiyoloji Derneği Arşivi}, year=2010, pages={334-340} }